Deutsch English Français

Contact

EP3728295

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3728295

EP3728295 - BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 10.02.2023 Database last updated on 11.09.2024
Former	Examination is in progress Status updated on 02.04.2022
Former	Request for examination was made Status updated on 25.09.2020
Former	The international publication has been made Status updated on 29.06.2019
Former	unknown Status updated on 26.01.2019
Most recent event Tooltip	10.02.2023	Application deemed to be withdrawn	published on 15.03.2023 [2023/11]
Applicant(s)	For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, California 92612 / US
	[2020/44]
Inventor(s)	01 / JACKY, Birgitte, PS 166 N. Waverly Street Orange, California 92866 / US
	02 / BRIDEAU-ANDERSEN, Amy 3214 Sanfre de Toro San Clemente, California 92673 / US
	03 / YOU, Hui 14201 Mirasol Irvine, California 92620 / US
	04 / FRAIL, Donald, E. 27753 Hidden Trail Road Laguna Hills, California 92653 / US
	05 / BRIN, Mitchell, F. 30 San Antonio Newport Beach, California 92660 / US
	[2020/44]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	[2020/44]
Application number, filing date	18834230.7	20.12.2018
	[2020/44]
	WO2018US66868
Priority number, date	US201762608119P	20.12.2017 Original published format: US 201762608119 P
	US201862727640P	06.09.2018 Original published format: US 201862727640 P
	[2020/44]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2019126542
	Date:	27.06.2019
	Language:	EN
	[2019/26]
	Type:	A1 Application with search report
	No.:	EP3728295
	Date:	28.10.2020
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 27.06.2019 takes the place of the publication of the European patent application.
	[2020/44]
Search report(s)	International search report - published on:	EP	27.06.2019
Classification	IPC:	C07K14/33, A61K38/48	[2020/44]
	CPC:	C12N9/52 (EP,IL,KR,US); A61K38/4893 (EP,IL,KR,US); A61K9/0014 (IL,US); A61K9/0019 (IL,US); A61P1/18 (EP,IL,US); A61P13/08 (EP,IL,US); (+) A61P13/10 (EP,IL,US); A61P17/02 (EP,IL,US); A61P17/06 (EP,IL,US); A61P17/08 (EP,IL,US); A61P17/10 (EP,IL,US); A61P29/00 (EP,IL,US); A61P35/00 (EP,IL,US); A61P37/00 (EP,IL,US); A61P43/00 (KR); A61Q19/007 (IL,US); A61Q19/008 (IL,US); A61Q19/08 (IL,US); C07K14/315 (IL,US); C07K14/33 (EP,IL,KR,US); C12Y304/24069 (EP,IL,KR,US); C07K2319/00 (IL,US); Y02A50/30 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/44]
Title	German:	BOTULINUMTOXIN-ZELLBINDUNGSDOMÄNEN-POLYPEPTIDE UND VERFAHREN ZUR VERWENDUNG FÜR BEHANDLUNGEN VON FIBROSE-ASSOZIIERTEN ERKRANKUNGEN	[2020/44]
	English:	BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS	[2020/44]
	French:	POLYPEPTIDES DU DOMAINE DE LIAISON CELLULAIRE DE TOXINE BOTULIQUE ET PROCÉDÉS D'UTILISATION POUR DES TRAITEMENTS DE TROUBLES ASSOCIÉS À LA FIBROSE	[2020/44]
Entry into regional phase	16.07.2020	National basic fee paid
	16.07.2020	Designation fee(s) paid
	16.07.2020	Examination fee paid
Examination procedure	16.07.2020	Amendment by applicant (claims and/or description)
	16.07.2020	Examination requested [2020/44]
	16.07.2020	Date on which the examining division has become responsible
	05.04.2022	Despatch of a communication from the examining division (Time limit: M06)
	18.10.2022	Application deemed to be withdrawn, date of legal effect [2023/11]
	09.11.2022	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/11]
Fees paid	Renewal fee
	28.12.2020	Renewal fee patent year 03
	16.12.2021	Renewal fee patent year 04
	09.12.2022	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO0005252 (AGRICULTURAL RESEARCH COUNCIL [ZA], et al) [X] 10-25,27,30-37 * whole document esp. seq id no 2; claims 3-4,6-8,13-16,22,26-27,32 *;
		[X]US2005095251 (STEWARD LANCE E [US], et al) [X] 10-26,30-37 * whole document esp. seq id no 9; paragraphs [54,57,68,81,82] *;
		[X]WO2009023549 (UNIV ROCHESTER [US], et al) [X] 30-37 * whole document esp. seq id no 5; paragraphs [39,138] *;
		[X]WO2009042165 (UNIV JEFFERSON [US], et al) [X] 1-37 * whole document esp. seq id no 14; paragraphs [14-16, 37, 58, 101,146]; claims 1,8-9 *;
		[X]WO2011018665 (MEDICAL RES COUNCIL [GB], et al) [X] 10-26,30-37 * whole document esp. seq id no 72; page 20 *;
		[X]KR20170138245 (AGENCY DEFENSE DEV [KR]) [X] 30-37 * whole document esp. seq id no 8; paragraphs [17,24]; claims 8,9 *;
		[Y] - ANNA I. ARNO ET AL, "Up-to-date approach to manage keloids and hypertrophic scars: A useful guide", BURNS., GB, (20141101), vol. 40, no. 7, doi:10.1016/j.burns.2014.02.011, ISSN 0305-4179, pages 1255 - 1266, XP055537740 [Y] 1-38 * whole document esp. pages 1255,1261 * DOI: http://dx.doi.org/10.1016/j.burns.2014.02.011
		[Y] - GUORUI YAO ET AL, "Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H", TOXINS, (20170308), vol. 9, no. 93, doi:10.3390/toxins9030093, pages 1 - 13, XP055500224 [Y] 1-38 * whole document esp. pages 1,8-9 * DOI: http://dx.doi.org/10.3390/toxins9030093
		[Y] - ALON BEN DAVID ET AL, "Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate", PROTEIN EXPRESSION AND PURIFICATION., SAN DIEGO, CA., (20150601), vol. 110, doi:10.1016/j.pep.2015.02.008, ISSN 1046-5928, pages 122 - 129, XP055562670 [Y] 1-38 * whole document esp. abstract, page 128 * DOI: http://dx.doi.org/10.1016/j.pep.2015.02.008
		[Y] - RICHARD M. KOSTRZEWA ET AL, "Botulinum neurotoxin: Progress in negating its neurotoxicity; and in extending its therapeutic utility via molecular engineering. MiniReview", PEPTIDES, AMSTERDAM, NL, (20151001), vol. 72, doi:10.1016/j.peptides.2015.07.003, ISSN 0196-9781, pages 80 - 87, XP055562643 [Y] 1-38 * whole document esp. abstract and pages 82,83,84 * DOI: http://dx.doi.org/10.1016/j.peptides.2015.07.003
		[YP] - JONATHAN DAVIES ET AL, "Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics", TOXINS, CH, (20181001), vol. 10, no. 10, doi:10.3390/toxins10100421, ISSN 2072-6651, page 421, XP055562661 [YP] 1-38 * the whole document * DOI: http://dx.doi.org/10.3390/toxins10100421
		[YP] - EVAN AUSTIN ET AL, "The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A : A Comprehensive Literature Review", DERMATOLOGIC SURGERY., NEW YORK, US, (20180201), vol. 44, no. 2, doi:10.1097/DSS.0000000000001360, ISSN 1076-0512, pages 149 - 157, XP055562632 [YP] 1-38 * the whole document * DOI: http://dx.doi.org/10.1097/DSS.0000000000001360
	by applicant	US8962548
		US296006
		US5008110
		US5364791
		US5464758
		US5514578
		US5591767
		US5683712
		US5814618
		US5874534
		US5899880
		US5902565
		US5935934
		US5948433
		US5965154
		US5980948
		US6004286
		US6010715
		US6010478
		US6013050
		US6051239
		US6053889
		US6165500
		US6306423
		US6312708
		US6383509
		US6506399
		US6585993
		US6747014
		US6923976
		US7172764
		US7255865
		US7645570
		US7704524
		US7727537
		US7749514
		US7892565
		US8067231
		US8092788
		US8124357
		US8168206
		US8398997
		US8404249
		US8486422
		US8512992
		US8518414
		US8568740
		US8603028
		US8618261
		US8642047
		US8697413
		US8801659
		US8841111
		US8926991
		US8974774
		US9044477
		US9050336
		US9107815
		US9144692
		US9161970
		US9180081
		US9211248
		US9278140
		US9284545
	US9622957
	- CHEMICAL ABSTRACTS, Database accession no. BAE48264
	- CHEMICAL ABSTRACTS, Database accession no. P18640
	- CHEMICAL ABSTRACTS, Database accession no. P19321
	- CHEMICAL ABSTRACTS, Database accession no. EF378947
	- "GENBANK", Database accession no. AFV91344
	- CHEMICAL ABSTRACTS, Database accession no. ABS41202
	- "GENBANK", Database accession no. X74162
	- "GENBANK", Database accession no. BAQ12790
	- DOVER et al., J Infect Dis., (20140000), vol. 209, no. 2, pages 192 - 202
	- MASLANKA et al., 1 Infect Dis., (20160000), vol. 213, no. 3, pages 379 - 385
	- PECK et al., Toxins (Review, (20170000), vol. 9, no. 1, page 38
	- ROSSETTO et al., Nature Reviews Microbiol, (20140000), vol. 12, pages 535 - 49
	- ARNDT et al., JMol Biol., (20060000), vol. 362, no. 4, pages 733 - 42
	- HILL et al., JBacteriol, (20070000), vol. 189, pages 818 - 32
	- RAPHAEL et al., Appl Environ Microbiol, (20120000), vol. 76, no. 14, pages 4805 - 12
	- KALB et al., Anal Chem., (20140000), vol. 86, pages 3254 - 62
	- MONTECUCCO et al., MBio, (20150000), vol. 6, pages e02131 - 14
	- "UNIPROT", Database accession no. PODPI1
	- "GENBANK", Database accession no. CAA44558
	- "GENBANK", Database accession no. KG015617
	- "UNIPROT", Database accession no. P04958
	- CHEMICAL ABSTRACTS, Database accession no. AF488749
	- CHEMICAL ABSTRACTS, Database accession no. AB232927
	- CHEMICAL ABSTRACTS, Database accession no. CAA47060
	- CHEMICAL ABSTRACTS, Database accession no. X54254
	- "UNIPROT", Database accession no. P19321
	- CHEMICAL ABSTRACTS, Database accession no. JX424539
	- CHEMICAL ABSTRACTS, Database accession no. X74162
	- "UNIPROT", Database accession no. Q60393
	- CHEMICAL ABSTRACTS, Database accession no. BAQ12790
	- CHEMICAL ABSTRACTS, Database accession no. OT022244
	- "UNIPROT", Database accession no. AOA242DI27
	- CHEMICAL ABSTRACTS, Database accession no. AB443580
	- CHEMICAL ABSTRACTS, Database accession no. X73423
	- "GENBANK", Database accession no. DQ185900
	- "GENBANK", Database accession no. EU341307
	- "GENBANK", Database accession no. HM153705
	- "GENBANK", Database accession no. FJ981696
	- "GENBANK", Database accession no. JQ954969
	- RISLER et al., J. Mol. Biol., (19880000), vol. 204, pages 1019 - 1029
	- NIEFIND et al., J. Mol. Biol., (19910000), vol. 219, pages 481 - 497
	- OVERINGTON et al., Protein Science, (19920000), vol. 1, pages 216 - 226
	- THOMAS et al., Chemical Communications, (20120000), vol. 48, pages 10559 - 10561
	- "UNIPROT", Database accession no. P10844
	- "UNIPROT", Database accession no. Q00496
	- "UNIPROT", Database accession no. P30996
	- "UNIPROT", Database accession no. Q45851
	- "UNIPROT", Database accession no. P30995
	- ZUCKERMANN, J. Am. Chem. Soc., (19920000), vol. 114, page 10646
	- CHADDOCK, Trends Biochem. Sci., (20020000), vol. 27, pages 552 - 558
	- SCHIAND, Physio. Rev., (20000000), vol. 80, pages 717 - 755
	- LI, Biochemistry, (20000000), vol. 39, pages 6466 - 6474
	- MONTECUCCO, Trends Biochem. Sci., (19930000), vol. 18, pages 324 - 327
	- LI, Toxin Rev., (19990000), vol. 18, pages 95 - 112
	- MONTECUCCO, Q. Rev. Biophys, (19950000), vol. 28, pages 423 - 472
	- LI, Biochemistry, (20000000), vol. 39, pages 2399 - 2405
	- AGARWAL, Biochemistry, (20050000), vol. 44, pages 8291 - 8302
	- MIZANUR et al., PLoS One, (20140000), vol. 9, no. 4, page e95188
	- ATASSI et al., Protein J., (20040000), vol. 23, no. 1, pages 39 - 52
	- ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
	- GISH et al., Nature Genet, (19930000), vol. 3, pages 266 - 272
	- MADDEN et al., Meth. Enzymol., (19960000), vol. 266, pages 131 - 141
	- ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
	- ZHANG et al., Genome Res., (19970000), vol. 7, pages 649 - 656
	- WITTLIEB et al., PNAS USA, (20060000), vol. 103, no. 16, pages 6208 - 11
	- PANKOW et al., PLoS One, (20070000), vol. 2, no. 9, page e782
	- KHALTURIN et al., PLoS Biol., (20080000), vol. 6, no. 11, page e278
	- "Introducing Cloned Genes into Cultured Mammalian Cells", Molecular Cloning A Laboratory Manual, (20010000), vol. 3, pages 16.1 - 16.62
	- MARTIN JORDAN; FLORIAN WORM, "Transfection of Adherent and Suspended Cells by Calcium Phosphate", Methods, (20040000), vol. 33, no. 2, doi:doi:10.1016/j.ymeth.2003.11.011, pages 136 - 143, XP004505455 DOI: http://dx.doi.org/10.1016/j.ymeth.2003.11.011
	- CHUN ZHANG et al., "Polyethylenimine Strategies for Plasmid Delivery to Brain-Derived Cells", Methods, (20040000), vol. 33, no. 2, doi:doi:10.1016/j.ymeth.2003.11.004, pages 144 - 150, XP004505456 DOI: http://dx.doi.org/10.1016/j.ymeth.2003.11.004
	- BIEWENGA et al., J. Neurosci. Methods, (19970000), vol. 71, no. 1, pages 67 - 75
	- O'BRIEN et al., Methods, (20040000), vol. 33, no. 2, pages 121 - 125
	- M. GOLZIO et al., Methods, (20040000), vol. 33, no. 2, pages 126 - 135
	- GRESCH et al., Methods, (20040000), vol. 33, no. 2, pages 151 - 163
	- BLESCH et al., Methods, (20040000), vol. 33, no. 2, pages 164 - 172
	- FEDERICO et al., MethodsMol. Biol., (20030000), vol. 229, pages 3 - 15
	- POESCHLA et al., Curr. Opin. Mol. Ther., (20030000), vol. 5, no. 5, pages 529 - 540
	- BENIHOUD et al., Curr. Opin. Biotechnol., (19990000), vol. 10, no. 5, pages 440 - 447
	- BUELER et al., Biol. Chem., (19990000), vol. 380, no. 6, pages 613 - 622
	- LAI et al., DNA Cell Biol., (20020000), vol. 21, no. 12, pages 895 - 913
	- BURTON et al., DNA Cell Biol., (20020000), vol. 21, no. 12, pages 915 - 936
	- GRANDI, Methods, (20040000), vol. 33, no. 2, pages 179 - 186
	- FROLOV, PNAS USA, (19960000), vol. 93, no. 21, pages 11371 - 11377
	- EHRENGRUBER ET, Brain Res. Bull., (20020000), vol. 59, no. 1, pages 13 - 22
	- KOST et al., Trends Biotechnol, (20020000), vol. 20, no. 4, pages 173 - 180
	- HUSER et al., Am. J. Pharmacogenomics, (20030000), vol. 3, no. 1, pages 53 - 63
	- HERMENS, J. Neurosci. Methods, (19970000), vol. 71, no. 1, pages 85 - 98
	- MIZUGUCHI et al., Adv. Drug Deliv. Rev., (20010000), vol. 52, no. 3, pages 165 - 176
	- TONINI et al., MethodsMol. Biol., (20040000), vol. 285, pages 141 - 148
	- RECILLAS-TARGA et al., Methods Mol. Biol., (20040000), vol. 267, pages 417 - 433
	- WOLKOWICZ, Methods Mol. Biol., (20040000), vol. 246, pages 391 - 411
	- NALDINI et al., Science, (19960000), vol. 272, no. 5259, pages 263 - 267
	- RAI et al., Curr. Sci., (20010000), vol. 80, no. 9, pages 1121 - 1128
	- GASSNER et al., Plast Reconstr Surg, (20000000), vol. 105, pages 1948 - 1953
	- ZHIBO et al., Plast Reconstr Surg., (20090000), vol. 124, no. 5, pages 275 - 277
	- DOKUR et al., Ann Surg Treat Res., (20170000), vol. 93, no. 1, pages 50 - 56
	- RAGHU et al., Am J Respir Crit Care Med, (20060000), vol. 174, pages 810 - 816
	- RAGHU et al., Am J Respir Crit Care Med, (20110000), vol. 183, pages 788 - 824
	- THABUT et al., Annals of Internal Medicine, (20090000), vol. 151, pages 767 - 774
	- "GENBANK", Database accession no. AF488749
	- "GENBANK", Database accession no. BAE48264
	- "GENBANK", Database accession no. P19321
	- "GENBANK", Database accession no. ABS41202

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p